The novel alkylating prodrug J1: diagnosis directed activity profile ex vivo and combination analyses in vitroMalin Wickström, Joachim Gullbo, Caroline Haglund et al.|Investigational New Drugs|2007Cited by 40
First-in-human dose-escalation study of NBF-006, a novel investigational siRNA targeting GSTP, in patients with non-small cell lung, pancreatic, or colorectal cancer.Anthony W. Tolcher, Sonya Zabludoff, Hirva Mamdani et al.|Journal of Clinical Oncology|2023Cited by 13